H.R. 6038 — To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.

Summary

Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were developed at a qualified nonprofit institution of higher education.

Full Text

Legislative Actions

1992-09-25
Introduced in House
1992-09-25
Introduced in House
1992-09-25
Referred to the House Committee on Judiciary.
1992-09-28
Referred to the Subcommittee on Intellectual Property and Judicial Administration.

To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill